COCP Logo

Cocrystal Pharma, Inc. (COCP) 

NASDAQ
Market Cap
$17.8M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
499 of 776
Rank in Industry
268 of 433

Largest Insider Buys in Sector

COCP Stock Price History Chart

COCP Stock Performance

About Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials …

Insider Activity of Cocrystal Pharma, Inc.

Over the last 12 months, insiders at Cocrystal Pharma, Inc. have bought $0 and sold $0 worth of Cocrystal Pharma, Inc. stock.

On average, over the past 5 years, insiders at Cocrystal Pharma, Inc. have bought $1.02M and sold $1.7M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,015,229 shares for transaction amount of $2M was made by FROST PHILLIP MD ET AL () on 2023‑04‑04.

List of Insider Buy and Sell Transactions, Cocrystal Pharma, Inc.

2023-04-04Purchase
1.02M
11.981%
$1.97$2M-6.34%
2021-08-20Purchasedirector
40,000
0.0414%
$1.03$41,120-46.08%
2021-05-04Sale10 percent owner
575,000
0.9104%
$2.95$1.7M-56.54%
2019-10-25Purchase10 percent owner
7,906
0.0202%
$1.15$9,092-14.81%
2019-10-24Purchase10 percent owner
5,094
0.0122%
$1.15$5,858-20.00%
2019-10-23Purchase10 percent owner
3,935
0.0085%
$1.04$4,087-20.00%
2016-12-23Sale
2.2M
0.343%
$0.44$968,000-37.50%
2016-09-01Purchase
10,000
0.0015%
$0.41$4,100-30.00%
2016-09-01Purchase
4.88M
0.7103%
$0.41$2M-30.00%
2016-09-01Purchase
10,000
0.0015%
$0.41$4,100-30.00%
2016-03-15Purchase
2.94M
0.3532%
$0.51$1.5M-22.95%
2016-03-15Purchase
2.94M
0.3532%
$0.51$1.5M-22.95%
2016-03-15Purchase
49,020
0.0059%
$0.51$25,000-22.95%
2016-03-15Purchase
1.24M
0.1484%
$0.51$630,000-22.95%
2016-03-15Purchase
39,216
0.0047%
$0.51$20,000-22.95%
2016-03-15Purchase
294,118
0.0353%
$0.51$150,000-22.95%
2016-03-15Purchase
50,000
0.006%
$0.51$25,500-22.95%
2015-12-23Purchase
100,000
0.0151%
$0.58$57,870-3.64%
2015-04-21Purchase
3.46M
0.4605%
$0.92$3.19M-26.00%
2015-03-25Purchase
3.46M
0.4593%
$0.92$3.19M-22.77%

Insider Historical Profitability

<0.0001%
WILCOX GARY
16948605
166.5907%
$1.7530
Schinazi Raymond F10 percent owner
7674960
75.4385%
$1.7561<0.0001%
HSIAO JANE PH D
3435294
33.7661%
$1.7520
FROST PHILLIP MD ET AL
1319838
12.9729%
$1.7560<0.0001%
Rubin Steven D
733484
7.2095%
$1.7520

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.